🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a multinational, randomised, double-blind, placebo-controlled, par...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT01820559
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of eslicarba...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-07
Trial ID
NCT00957047
Treatments Being Tested
Single-blind, single-centre, fixed-order study to evaluate the PD effects o...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT02284828
Treatments Being Tested
The primary objective of the study is to assess the efficacy of eslicarbaze...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00981227
Treatments Being Tested
The primary objective was to evaluate the efficacy of eslicarbazepine aceta...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-12
Trial ID
NCT00957372
Treatments Being Tested
This was a double-blind, randomised, placebo-controlled, parallel-group, mu...
Status
Completed
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT01820585
Treatments Being Tested
Single centre, two-way crossover, randomised, open-label study in 20 health...
Status
Completed
Location
BIAL - Portela & Cª, S.A.
Start Date
2005-03
Trial ID
NCT02281448
Treatments Being Tested
The purpose of this study is to investigate the safety and tolerability of ...
Status
Completed
Location
Guy's Drug Research Unit
Start Date
2001-02
Trial ID
NCT02171234
This is an 18-week, double-blind, multicenter study with gradual conversion...
Status
Completed
Location
University of Arizona Health Sciences Center
Start Date
2010-06
Trial ID
NCT01091662
Treatments Being Tested
This was a phase III 4-part study in multiple centres. Part I was a 26-week...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-07
Trial ID
NCT00957684
Treatments Being Tested